undamentalytics Newsletter
Sign in

Rxsight, Inc. balance sheet

At the end of fiscal 2025, Rxsight, Inc. had total assets of $312m, total liabilities of $36.1m and shareholders' equity of $276m. It held $19.9m in cash against $0 of debt: net cash of $19.9m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents14241210172013
Receivables351120302319
Inventory881517223237
Total current assets82176135168294287327
Total assets101193150183319312353
Accounts payable1234556
Deferred revenue (current)0112347
Total current liabilities12111721262680
Long-term debt2440400———
Total debt2440400000
Total liabilities45546022373689
Shareholders' equity−43113890160281276263
Non-controlling interests and other (assets − liabilities − equity)486——————
Net debt (negative = net cash)101628−10−17−20−13
Shares outstanding—27m28m36m40m41m42m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: BBNX vs RXSTANIK vs RXSTOM vs RXSTINFU vs RXST

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Rxsight, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Rxsight, Inc.